Zhong Huijuan
$10.17B
$103.8M (1%)
as of 11/22/24
About Zhong Huijuan
Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs.
Zhong's husband, Sun Piaoyang, is also a pharmaceuticals billionaire and leads Shanghai-listed Jiangsu Hengrui Medicine.
Their daughter, Sun Yuan, is Hansoh's executive director.
Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019.
Hansoh partnered to develop an oral Covid treatment with Bill & Melinda Gates Foundation-backed Global Health Drug Discovery Institute in 2022.
Personal stats
Citizenship
People's Republic of ChinaSource of wealth
PharmaceuticalsResidence
Shanghai, People's Republic of ChinaMarital status
MarriedBirth date
01/01/61 (age 63)Number of children
1Education
Bachelor of Science, Jiangsu Normal University; EMBA, Nanjing UniversitySelf-made
self-madeZhong Huijuan’s fortune is worth
169K
troy ounces of gold
156K
median U.S. household
102K
median U.S. income
0.203%
U.S. credit card volume
0.041%
GDP of the United States
0.03%
United States debt
Net worth history
Annual ranking
Related people
Net worth over time
Real-time ranking
Financial assets
HONG KONG | 3692-HK
Hansoh Pharmaceutical GroupSHANGHAI | 600276-CN
Jiangsu Hengrui MedicineImages © Forbes.com. All rights reserved.